Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC). Issue 6 (June 2017) - Redana, S.; Papadimitraki, E.; Mohammed, K.; Lote, H.; Sharp, A.; Capelan, M.